NCT00933894
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
Not specified
Clinical trial condition
Blood-Borne Infections
Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.
8,267 public trials
445 recruiting studies
Blood-Borne Infections trial results
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
- Locations
-
Not specified
NCT00903773
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
- Locations
-
Not specified
Completed
Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100
NCT00385957
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Hospital de la Santa Creu i Sant Pau Barcelona, Spain
- Hospital Vall d'Hebron Barcelona, Spain
- Hospital Clinic Barcelona, Spain
- CSU Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
NCT00403585
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
- Locations
-
- GSK Investigational Site Seoul, South Korea
NCT01259453
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Hispanic Health Council Hartford, Connecticut, United States
- DePaul University Chicago, Illinois, United States
- Case Western Reserve Universtiy Cleveland, Ohio, United States
NCT00237432
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- Rockefeller University Hospital New York, United States
NCT01254994
- Conditions
- Acute-On-Chronic Liver Failure, Blood-Borne Infections, Communicable Diseases, +12 more
- Locations
-
- The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Beverly Hills, California, United States
- Pfizer Investigational Site Fountain Valley, California, United States
Completed
Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
NCT00617643
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
- Locations
-
- Infectious Diseases Institute, Faculty of Medicine, Makerere University Kampala, Uganda